Achiko AG (Achiko AG) Liabilities-to-Assets : 3.94 (As of Jun. 2022)

View and export this data going back to 2020. Start your Free Trial

What is Achiko AG Liabilities-to-Assets?

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Achiko AG's Total Liabilities for the quarter that ended in Jun. 2022 was $9.26 Mil. Achiko AG's Total Assets for the quarter that ended in Jun. 2022 was $2.35 Mil. Therefore, Achiko AG's Liabilities-to-Assets Ratio for the quarter that ended in Jun. 2022 was 3.94.

Achiko AG Liabilities-to-Assets Historical Data

The historical data trend for Achiko AG's Liabilities-to-Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Achiko AG Liabilities-to-Assets Chart

Achiko AG Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Liabilities-to-Assets

1.19

0.81

3.29

3.40

Achiko AG Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22
Liabilities-to-Assets	Get a 7-Day Free Trial			1.37	3.29	3.58	3.40	3.94

Competitive Comparison of Achiko AG's Liabilities-to-Assets

For the Health Information Services subindustry, Achiko AG's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Achiko AG's Liabilities-to-Assets Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Achiko AG's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Achiko AG's Liabilities-to-Assets falls into.

Achiko AG Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Achiko AG's Liabilities-to-Assets Ratio for the fiscal year that ended in Dec. 2021 is calculated as:

Liabilities-to-Assets (A: Dec. 2021 )	=	Total Liabilities	/	Total Assets
	=	6.499	/	1.914
	=	3.40

Achiko AG's Liabilities-to-Assets Ratio for the quarter that ended in Jun. 2022 is calculated as

Liabilities-to-Assets (Q: Jun. 2022 )	=	Total Liabilities	/	Total Assets
	=	9.256	/	2.348
	=	3.94

Achiko AG (OTCPK:ACHKF) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.

Achiko AG Liabilities-to-Assets Related Terms

Thank you for viewing the detailed overview of Achiko AG's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Achiko AG (Achiko AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Achiko AG (OTCPK:ACHKF) » Definitions » Liabilities-to-Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Tessinerplatz 7, Zurich, CHE, CH-8002

Website

https://www.achiko.com

Achiko AG is developing disruptive diagnostic solutions that put people first. The company product is a rapid, reliable Covid-19 test with a companion app offering a user-friendly digital health passport. Achiko creates and develops aptamer-based diagnostics through its biotechnology division, AptameX, and companion health apps via its digital mobile health technology division, Teman Sehat. The AptameX DNA aptamer tests can be rapidly chemically synthesized, are cost-effective, and have wide potential across multiple disease diagnostics. Leveraging AptameX and Teman Sehat, Achiko aims to deliver fast, accurate, and affordable diagnostic testing for a range of pathogenic diseases and therapeutic indications in the rapidly evolving healthcare diagnostics field.